LLY

1,020.69

-0.81%↓

JNJ

243.4

-0.72%↓

ABBV

224.52

-1.08%↓

NVS

165.19

-0.73%↓

MRK

119.22

-2.61%↓

LLY

1,020.69

-0.81%↓

JNJ

243.4

-0.72%↓

ABBV

224.52

-1.08%↓

NVS

165.19

-0.73%↓

MRK

119.22

-2.61%↓

LLY

1,020.69

-0.81%↓

JNJ

243.4

-0.72%↓

ABBV

224.52

-1.08%↓

NVS

165.19

-0.73%↓

MRK

119.22

-2.61%↓

LLY

1,020.69

-0.81%↓

JNJ

243.4

-0.72%↓

ABBV

224.52

-1.08%↓

NVS

165.19

-0.73%↓

MRK

119.22

-2.61%↓

LLY

1,020.69

-0.81%↓

JNJ

243.4

-0.72%↓

ABBV

224.52

-1.08%↓

NVS

165.19

-0.73%↓

MRK

119.22

-2.61%↓

Search

Integra LifeSciences Holdings Corp

Fermé

SecteurSoins de santé

11.26 -2.26

Résumé

Variation du prix de l'action

24h

Actuel

Min

10.58

Max

11.52

Chiffres clés

By Trading Economics

Revenu

479M

-5.4M

Ventes

-14M

402M

Marge bénéficiaire

-1.344

Employés

4,396

EBITDA

526M

54M

Recommandations

By TipRanks

Recommandations

Neutre

Prévisions sur 12 Mois

+12.17% upside

Dividendes

By Dow Jones

Prochains Résultats

26 févr. 2026

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

-340M

916M

Ouverture précédente

13.52

Clôture précédente

11.26

Sentiment de l'Actualité

By Acuity

50%

50%

167 / 351 Classement par Healthcare

Score Technique

By Trading Central

Confiance

Strong Bearish Evidence

Integra LifeSciences Holdings Corp Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

25 févr. 2026, 23:25 UTC

Actions en Tendance

Stocks to Watch: C3.ai, Salesforce, Pure Storage, Zoom

25 févr. 2026, 23:15 UTC

Résultats

Salesforce Sees Stable Growth; CEO Dismisses Talk of AI-Fueled 'SaaS-Pocalypse' -- 2nd Update

25 févr. 2026, 23:54 UTC

Market Talk

Gold Steady Ahead of U.S.-Iran Talks -- Market Talk

25 févr. 2026, 23:47 UTC

Résultats

Ferrovial 4Q Net EUR197M >FER.MC

25 févr. 2026, 23:45 UTC

Résultats

Ferrovial 4Q Rev EUR2.72B >FER.MC

25 févr. 2026, 23:42 UTC

Résultats

Nvidia Beats Back Bubble Fears With Record $68 Billion Sales in Fourth Quarter -- 4th Update

25 févr. 2026, 23:38 UTC

Market Talk

Nikkei May Rise, Tracking Wall Street's Gains -- Market Talk

25 févr. 2026, 23:25 UTC

Résultats

Trip.com: Company's Business Operations Remain Normal >TCOM

25 févr. 2026, 23:25 UTC

Résultats

Trip.com Gives Update on Investigation by China's State Administration for Market Regulation >TCOM

25 févr. 2026, 23:25 UTC

Résultats

Trip.com: Cannot Predict Status or Results of Investigation, Will Provide Updates on Conclusion >TCOM

25 févr. 2026, 23:25 UTC

Résultats

Trip.com Increase in FY Profit Primarily Due to Gain From Investments >TCOM

25 févr. 2026, 23:25 UTC

Résultats

Trip.com Will Continue to Communicate With SAMR on Compliance With Regulatory Requirements >TCOM

25 févr. 2026, 23:25 UTC

Résultats

Trip.com: SAMR Investigation Related to China's Anti-monopoly Law >TCOM

25 févr. 2026, 23:25 UTC

Résultats

Trip.com: Investigation Ongoing, Company Is Cooperating With SAMR >TCOM

25 févr. 2026, 23:25 UTC

Résultats

Trip.com Co-founders Min Fan, Qi Ji Resign From Positions >TCOM

25 févr. 2026, 23:25 UTC

Résultats

Trip.com: Fan Resigned as Director and President; Ji Resigned as a Director >TCOM

25 févr. 2026, 23:25 UTC

Résultats

Trip.com FY Rev CNY62.4B, Up 17% >TCOM

25 févr. 2026, 23:25 UTC

Résultats

Trip.com FY Net CNY33.3B Vs. Net CNY17.1B >TCOM

25 févr. 2026, 23:25 UTC

Résultats

Trip.com FY EPS CNY47.67 >TCOM

25 févr. 2026, 23:06 UTC

Résultats

Correction to Nvidia Fourth Quarter Results Article -- WSJ

25 févr. 2026, 23:01 UTC

Résultats

Nvidia Beats Back Bubble Fears With Record $68 Billion Sales in Fourth Quarter -- 3rd Update

25 févr. 2026, 23:00 UTC

Market Talk
Résultats

Global Equities Roundup: Market Talk

25 févr. 2026, 23:00 UTC

Market Talk
Résultats

Nvidia: Chinese Competitors Pose Risk to U.S. Dominance in AI -- Market Talk

25 févr. 2026, 22:56 UTC

Market Talk
Résultats

Nvidia CEO Says Customers Can't Grow Revenue Without Compute -- Market Talk

25 févr. 2026, 22:43 UTC

Résultats
Acquisitions, Fusions, Rachats

Paramount Streaming Revenue Rises, but TV Segment Faces Headwinds -- WSJ

25 févr. 2026, 22:40 UTC

Market Talk
Résultats

Nvidia Says Agentic AI Has Reached Inflection Point -- Market Talk

25 févr. 2026, 22:40 UTC

Résultats

Karoon Energy Says Search for New CFO Well Advanced

25 févr. 2026, 22:39 UTC

Résultats

Karoon Energy Says CFO Ray Church to Leave Company

25 févr. 2026, 22:39 UTC

Résultats

Karoon Energy Says On-Market Share Buyback Program Ongoing at Moderated Level

25 févr. 2026, 22:38 UTC

Résultats

Karoon Energy Says Guidance for 2026 Key Metrics Unchanged

Comparaison

Variation de prix

Integra LifeSciences Holdings Corp prévision

Objectif de Prix

By TipRanks

12.17% hausse

Prévisions sur 12 Mois

Moyen 13 USD  12.17%

Haut 13 USD

Bas 13 USD

Basé sur 2 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Neutre

2 ratings

0

Achat

2

Maintien

0

Vente

Score Technique

By Trading Central

12.75 / 16.41Support & Résistance

Court Terme

Strong Bearish Evidence

Moyen Terme

Strong Bearish Evidence

Long Terme

Weak Bearish Evidence

Sentiment

By Acuity

167 / 351Classement par Soins de santé

Sentiment de l'Actualité

Neutral

Volatilité

Inférieur à la moyenne

Changement du Volume d'Actualités (RCV)

Inférieur à la moyenne

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Integra LifeSciences Holdings Corp

Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical products, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment; and surgical headlamps and instrumentation, as well as after-market services. It also sells instrument patterns, and surgical and lighting products to hospitals and surgery centers, as well as dental, podiatry, and veterinary offices. In addition, the company provides regenerative technology products for the treatment of acute wounds; and surgical tissue repair products for hernia, tendon, peripheral nerve repair and protection. Further, it offers skin and wound repair, plastics and surgical reconstruction products, bone grafts, and nerve and tendon repair products. The company offers its products directly through various sales forces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, Asia Pacific, and internationally. Integra LifeSciences Holdings Corporation was incorporated in 1989 and is headquartered in Princeton, New Jersey.
help-icon Live chat